NasdaqGS - Delayed Quote USD

Solid Biosciences Inc. (SLDB)

8.98 +0.44 (+5.15%)
At close: April 26 at 4:00 PM EDT
8.97 -0.01 (-0.11%)
After hours: April 26 at 4:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
8,094.00
13,620.00
--
Operating Expense
104,315.00
104,315.00
107,368.00
85,874.00
86,462.00
Operating Income
-104,315.00
-104,315.00
-99,274.00
-72,254.00
-86,462.00
Net Non Operating Interest Income Expense
7,142.00
7,142.00
2,616.00
64.00
115.00
Other Income Expense
1,158.00
1,158.00
10,677.00
2.00
-1,943.00
Pretax Income
-96,015.00
-96,015.00
-85,981.00
-72,188.00
-88,290.00
Net Income Common Stockholders
-96,015.00
-96,015.00
-85,981.00
-72,188.00
-88,290.00
Diluted NI Available to Com Stockholders
-96,015.00
-96,015.00
-85,981.00
-72,188.00
-88,290.00
Basic EPS
73.71
-4.83
-10.10
-10.14
-25.50
Diluted EPS
73.71
-4.83
-10.10
-10.14
-25.50
Basic Average Shares
9,124.68
19,884.01
8,512.09
7,118.02
3,462.48
Diluted Average Shares
9,124.68
19,884.01
8,512.09
7,118.02
3,462.48
Total Operating Income as Reported
-104,252.00
-104,252.00
-106,452.00
-72,254.00
-88,406.00
Total Expenses
104,315.00
104,315.00
107,368.00
85,874.00
86,462.00
Net Income from Continuing & Discontinued Operation
-96,015.00
-96,015.00
-85,981.00
-72,188.00
-88,290.00
Normalized Income
-96,078.00
-96,078.00
-97,039.00
-72,188.00
-86,346.00
Interest Income
7,142.00
7,142.00
2,616.00
64.00
115.00
Net Interest Income
7,142.00
7,142.00
2,616.00
64.00
115.00
EBIT
-104,315.00
-104,315.00
-99,274.00
-72,254.00
-86,462.00
EBITDA
-101,734.00
-101,734.00
-96,866.00
-69,290.00
-82,540.00
Reconciled Depreciation
2,581.00
2,581.00
2,408.00
2,964.00
3,922.00
Net Income from Continuing Operation Net Minority Interest
-96,015.00
-96,015.00
-85,981.00
-72,188.00
-88,290.00
Total Unusual Items Excluding Goodwill
63.00
63.00
11,058.00
--
-1,944.00
Total Unusual Items
63.00
63.00
11,058.00
--
-1,944.00
Normalized EBITDA
-101,797.00
-101,797.00
-107,924.00
-69,290.00
-80,596.00
12/31/2020 - 1/26/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VYGR Voyager Therapeutics, Inc.
7.62
+2.70%
 
RGNX REGENXBIO Inc.
16.19
+0.81%
 
DTIL Precision BioSciences, Inc.
9.38
-3.50%
 
APRE Aprea Therapeutics, Inc.
5.20
-2.07%
 
HOWL Werewolf Therapeutics, Inc.
6.75
+8.70%
 
ATXS Astria Therapeutics, Inc.
9.00
-1.85%
 
AVRO AVROBIO, Inc.
1.2100
+2.11%
 
DNTH Dianthus Therapeutics, Inc.
21.50
+2.43%
 
ALEC Alector, Inc.
5.25
+9.15%
 
IMCR Immunocore Holdings plc
58.46
+0.79%